je.st
news
Arrowhead Announces Pricing of Underwritten Offering of Common Stock
2014-02-19 22:48:24| Biotech - Topix.net
Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced the pricing of an underwritten offering of 5,500,000 shares of its common stock, offered at a price of $18.95 per share.
Tags: stock
common
offering
pricing
Category:Biotechnology and Pharmaceuticals